Influence of metabolic risk factors of cardiovascular diseases on cognitive impairment in elderly patients;Zaburzenia poznawcze u osób starszych w świetle oceny metabolicznych czynników ryzyka chorób sercowo-naczyniowych

Acta Angiologica

Volumn 11, Issue 1, 2005, Pages 37-49

  Kwiatkowska, Wiesława ^a,b   Szczepańska, Joanna ^c   Woźniewski, Marek ^c   Greń, Grazyna ^b,d  

^a Regional Railway Hospital of Wroclaw   (Poland)

^b Szpital Specjalistycznego ^*  (Poland)

^c UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^d Specialist Psychiatric Health Care Centre   (Poland)

Author keywords

Atherosclerosis; Carotid arteries; Cognitive impairment; Dementia; Diabetes; Lipids; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

EID: 18344389579     PISSN: 1234950X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ferrucci L, Guralink JM, Salive ME, Pahor M, Corti MC, Baroni A, Havlik RJ (1996) Cognitive impairment and risk of stroke in the older population. JAGS, 44: 237-241.
2. Kluger A, Gianutsos JG, Golomb J, Ferris SH, Reisberg B (1997) Motor/psychomotor dysfunction in normal aging, mild cognitive decline and early Alzheimer's disease: diagnostic and differential diagnostic features. Int Psychogeriatr, 9: 307-316.
3. Maureen A Thornby (1997) Rownowaga i upadki u ostabionej starszej osoby: przeglad literatury. Rehabilitacja Medyczna, 1: 11-19.
4. Belcaro G, Nicolaides AN, Laurora G (1996) Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study. Arteriosclerosis, Thrombosis, and Vascular Biology, 17: 851-856.
5. Datek B, Czernicki J (1999) Testy w ocenie sprawności funkcjonalnej pacjenta w wieku podesztym. Fizjoterapia, 7: 47-51.
6. Glen MJ, Palmer MR (1999) Metody okreslenia stopnia nieporadnosci osob w podesztym wieku. Medycyna po Dyplomie, 8: 6.
7. Gambert SR (1998) Czy to choroba Alzheimera? Medycyna po Dyplomie (Wydanie specjalne - Choroba Alzheimera), 3.
8. Kwiatkowska W, Kwiatkowski J, Kawa K (1998) Evaluation of the vascular wall by the computer measurement system. Mosis, 61-68.
9. ATP III Metabolic Syndrome Criteria. Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adluts (2001) (Adults Treatment Panel 111).
10. Asimakopoulou K, Hampson AE (2002) Cognitive functioning and self-management in older people with diabetes. Diabetes Spectrum, 15: 116-121.
11. Auperin A, Berr C, Bonithon-Kopp C et al (1996) Ultrasonographic assessement of carotid wall characteristics and cognitive functions in a community sample of 59- to 71 -year-olds. Stroke, 27: 1290-1295.
12. De la Torre JC (2002) Alzheimer disease as a vascular disorder. Stroke, 33: 1152.
13. Gregg WW, Brown A (2003) Cognitive and physical disabilities and aging-related complications of diabetes. Clinical Diabetes, 21: 113-118.
14. Johnston SC, O'Meara ES, Manolino TA et al (2004) Cognitive impairment and decline are associated with carotid disease in patients without clinically evident cerebrovascular disease. Ann Int Med, 140: 237-247.
15. Knopman D, Boland LL, Mosley T et al (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology, 56: 42-48.
16. Luchsinger JA, Tang MX, Stern J et al (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in multiethnic cohort. Am J Epidemiol, 154: 635-641.
17. Ott A, Stolk RP, Van Harskamp F (1999) Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology, 53: 1937.
18. Skoog I (1998) Status of risk factors for vascular dementia. Neuroepidemiology, 17: 2-9.
19. Yaffe K, Connor-Barrett E, Lin F et al (2002) Serum lipoprotein levels, statin use and cognitive function in older women. Arch Neurol, 59: 378-384.
20. Van Exel E, De Craen AJM, Gussekloo J et al (2002) Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol, 51: 716-721.
21. Fagan Niven AM. Vascular dementia: complex pathology, confusing symptoms (www.alzheimers-illinois.org).
22. Kivipelto M, Helkala EL, Laakso MP et al (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal population based study. BMJ, 322: 1447-1451.
23. Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diab Med, 16: 93-112.
24. -4. Maalikiy AN, Boroni B, Agosti C et al (2003) Volume reduction in cerebral blood flow in patients with Alzheimer's disease: a sonographic study. Demen Geriatr Cogn Disord, 16: 163-169.
25. Rao R (2002) The role of carotid stenosis in vascular cognitive impairment. J Neurol Scien, 203-204: 103-107.
26. Kalmijn S, Foley D, White L et al (2000) Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men. The Honolulu-Asia Aging Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20: 2255.
27. Razay G, Wocock GK (1994) Hipeinsulinaemia and Alzheimer's disease. Age and Ageing, 23: 396-399.
28. Liolitsa D, Powell J, Lovestone S (2002) Genetic variability in the insulin signaling pathway may contribute to the risk of late onset Alzheimer's disease. J Neurol, Neurosurg and Psych, 73: 261-266.